Monitoring the immune response in sepsis: A rational approach to administration of immunoadjuvant therapies

Keyphrases

• Immune Response 100%
• Sepsis 100%
• Immunoadjuvant 100%
• High Risk 50%
• Functional Testing 50%
• Immune Function 50%
• Risk of Death 50%
• Surrogate Marker 50%
• Septic Patients 50%
• Rapidly Evolving 50%
• Nosocomial Infection 50%
• Clinical Trial Design 50%
• Robust Biomarker 50%
• Right Time 50%
• Immune Status 50%
• Monocyte HLA-DR 50%
• Immune Stimulation 50%
• Immune Alterations 50%
• Routine Conditions 50%
• Immunostimulating 50%

Medicine and Dentistry

• Immune Response 100%
• Sepsis 100%
• Immunity 100%
• Immunological Adjuvant 100%
• Biological Marker 66%
• Clinical Trial 33%
• Hospital Infection 33%
• Disease Marker 33%
• Immunity 33%

Immunology and Microbiology

• Immune Response 100%
• Immunity 100%
• Immunologic Adjuvant 100%
• HLA-DR 33%
• Immunity 33%